Document Detail


Research paths to successful prevention and treatment of swine-derived H1N1 influenza virus infection.
MedLine Citation:
PMID:  20155220     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Despite the fact that the threat of a new influenza pandemic has been hovering over us for quite some time, the truth is that the weapons currently licensed for fighting the swine-derived H1N1 virus are not quite up to the current needs. Although considerable effort has been put into developing new vaccines and antivirals, the available agents are basically the same ones as 10 years ago. In this review, we consider novel prophylactic and therapeutic alternatives, which luckily are being proposed by experts in the field. The better understanding and basic knowledge of influenza viruses, including their high variability and potential for antigenic drift, has prompted the development of new antivirals and more efficacious vaccines that hold promise for the near future.
Authors:
Esperanza G?mez-Luc?a; Fernando Rodr?guez
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Drug news & perspectives     Volume:  23     ISSN:  0214-0934     ISO Abbreviation:  Drug News Perspect.     Publication Date:    2010 Jan-Feb
Date Detail:
Created Date:  2010-02-15     Completed Date:  2010-05-11     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8809164     Medline TA:  Drug News Perspect     Country:  Spain    
Other Details:
Languages:  eng     Pagination:  65-70     Citation Subset:  IM    
Affiliation:
Department of Animal Health, Facultad de Veterinaria, Universidad Complutense, Madrid, Spain. duato@vet.ucm.es
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antiviral Agents / therapeutic use*
Disease Outbreaks
Drug Resistance, Viral
Humans
Influenza A Virus, H1N1 Subtype*
Influenza Vaccines / immunology*
Influenza, Human / drug therapy*,  prevention & control*
Vaccination
Chemical
Reg. No./Substance:
0/Antiviral Agents; 0/Influenza Vaccines

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Overcoming the obstacles in the pharma/biotech industry: 2009 update.
Next Document:  European Medicines Agency support mechanisms fostering orphan drug development.